Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On FOX 50 at 10 : 6-month-old baby shot & one person is dead after a shooting. What police say happened tonight
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
131.20
+0.48 (+0.37%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,758,432
Open
130.13
Bid (Size)
130.73 (5)
Ask (Size)
133.04 (1)
Prev. Close
130.72
Today's Range
130.13 - 131.91
52wk Range
99.14 - 133.10
Shares Outstanding
2,531,374,696
Dividend Yield
2.23%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Stock Market Rebounds; Tesla, Microsoft, Google, Meta, Chipotle, GE In Focus: Weekly Review
Today 11:34 EDT
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Via
Investor's Business Daily
Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
Today 2:59 EDT
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Performance
YTD
+15.86%
+15.86%
1 Month
-0.42%
-0.42%
3 Month
+8.59%
+8.59%
6 Month
+27.60%
+27.60%
1 Year
+13.93%
+13.93%
More News
Read More
Merck (MRK) Q1 2024 Earnings Call Transcript
April 25, 2024
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Understanding Merck & Co's Position In Pharmaceuticals Industry Compared To Competitors
April 23, 2024
Via
Benzinga
Looking Into Merck & Co's Recent Short Interest
April 23, 2024
Via
Benzinga
3 Under-The-Radar Stocks With Positive Potential
April 21, 2024
Via
Talk Markets
Unveiling 17 Analyst Insights On Merck & Co
April 18, 2024
Via
Benzinga
Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
April 25, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
April 25, 2024
Via
Benzinga
S&P 500 Down Over 1%; Merck Increases 2024 Outlook
April 25, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Market Whales and Their Recent Bets on MRK Options
April 17, 2024
Via
Benzinga
MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024
April 25, 2024
Via
InvestorPlace
Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
April 25, 2024
Via
Benzinga
Merck Rides Keytruda To Another Beat-And-Raise, But Diabetes Headwinds Persist
April 25, 2024
Via
Investor's Business Daily
Merck Announces First-Quarter 2024 Financial Results
April 25, 2024
From
Merck & Co., Inc.
Via
Business Wire
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
April 24, 2024
Via
Benzinga
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
April 25, 2024
Via
Benzinga
Investor Alert: Prepare for the Market Crash With These 3 Stocks
April 23, 2024
Via
InvestorPlace
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
Via
InvestorPlace
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
April 17, 2024
Via
InvestorPlace
Exposures
Product Safety
3 Dow Stocks to Buy Now: Q2 Edition
April 16, 2024
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Healthcare Stocks Are Lagging With Big Earnings Weeks Ahead
April 16, 2024
Via
Talk Markets
Better Growth Play: Merck or The Vanguard Growth Index Fund?
April 15, 2024
Via
The Motley Fool
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
Merck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
April 14, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.